Amerikaanse aandelen « Terug naar discussie overzicht

POET Technologies Inc.

3.207 Posts, Pagina: « 1 2 3 4 5 6 ... 116 117 118 119 120 121 122 123 124 125 126 ... 157 158 159 160 161 » | Laatste
[verwijderd]
0
POET Technologies Announces Operational, Financial Position, "Lab-to-Fab" Transition, and Milestone Updates
TORONTO, ONTARIO and STORRS, CONNECTICUT--(Marketwired - Jan. 8, 2015) - POET Technologies Inc. (TSX VENTURE:PTK)(OTCQX:POETF) (the "Company") - developer of the planar opto-electronic technology ("POET") platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - today announced key operational, financial position, "Lab-to-Fab" transition, and milestone updates.

Financial Position

"POET enters 2015 in excellent financial shape," noted Mr. Peter Copetti, Co-Chairman and interim CEO. "Although we spent on outsourcing and capital equipment through 2014, we start the new year with a cash balance of approximately $12.5 million, a 350% increase from a year earlier. This is our strongest cash position as a company and will allow us to take advantage of opportunities in the following year to maximize shareholder value." In December 2014, the Company also signed a new lease extension with the University of Connecticut ("UCONN") for a 1-year period which was pre-paid at a significant discount. The new lease includes a possible further two-year extension and provides us the flexibility to transition from Lab to Fab.

Mr. Copetti added: "2014 has been a great year for POET where our transition from "Lab-to-Fab" has begun with many industry Non-Disclosure Agreement ("NDA") discussions that have been initiated through the work of Mr. Ajit Manocha, our Co-Chairman. Some of our milestones have had to evolve during 2014 because of industry relationship considerations and priorities. These evolving changes have made the updated milestones more significant to the market place. We enter 2015 with financial stability, significant industry relationships, and milestones relevant to the industry collaborators. The Company believes that we are in an excellent position to monetize our process technology."

"Lab-to-Fab" Transition: 100-nm and 40-nm Scaling Program Update

POET recently reported a contractual effort with a "3rd party foundry" to accelerate the transition from "Lab-to-Fab" of the POET technology to a manufacturing status at the 6" wafer scale. Significant progress has been made towards transfer of critical manufacturing steps to the "3rd party foundry". This flow will both accelerate and improve quality of results for prototype fabrication and test supporting process flow and design enablement kit development. Efforts in the lab have been geared towards optimization of the self-aligned contacts for the HFET transistors, as well as on optimization of the vertical structure of the devices. Mr. Daniel DeSimone, Chief Technology Officer noted: "We have seen positive improvement in the key figures of merit we test for in our devices. We see further possible improvements and are continuing to work on device and process flow to achieve the highest possible performance."

In a parallel development at the UCONN lab, a new additional sputter tool was received and accepted. The tool is nearing completion of internal qualification. Deployment of the new tool will drastically reduce prototype fabrication cycle times as well as improve the quality and process control of key films used in the process flow. These will be critical not only to current development, but also necessary for transfer to eventual manufacturing stages.

Milestone Updates

PET Foundation Process Design Kit ("PDK") targeting 40-nm - Sentaurus modeling (a Synopsys tool) has been performed with new fabrication innovations to achieve controlled scaled device operation. These modeling predictions are guiding and confirming the device prototype development and testing. The PDK milestone has been moved to Q1 2015 so that the release incorporates the latest innovations currently being developed in the UCONN Lab and in parallel with the "3rd party foundry".

"3rd Party Foundry" 40/100-nm Transfer - This "Lab-to-Fab" effort requires bringing up critical layers manufacturing capability in our "3rd party foundry" which enables more complex test structures. Significant progress has been achieved towards the completion of this milestone. The Company is very close to completing qualification runs for the flow in which the critical layers are performed at our "3rd party foundry". This new flow will significantly accelerate completion and optimization of development on 100 and 40-nm foundation devices and associated proof of concept optical and electronic circuit structures.

CEO Search Update

POET recently announced that Mr. Ajit Manocha, Co-Chairman had been appointed to the Corporate Governance and Nominating Committee, subject to Board approval, with the mandate to identify and consider candidates for the permanent Chief Executive Officer role. Mr. Manocha noted: "Several high quality candidates are being considered. We hope in the near term to identify POET's permanent CEO who will continue the process technology development and help us close key industry partnership deals. We look forward to identifying the right successor."

In addition, over the next few months, the Company intends to add directors, key executives and operational staff focusing on increasing POET's presence in the United States.
DeZwarteRidder
0
quote:

sevenOdouble schreef op 8 januari 2015 15:16:

POET Technologies Announces Operational, Financial Position, "Lab-to-Fab" Transition, and Milestone Updates
TORONTO, ONTARIO and STORRS, CONNECTICUT--(Marketwired - Jan. 8, 2015) - POET Technologies Inc. (TSX VENTURE:PTK)(OTCQX:POETF) (the "Company") - developer of the planar opto-electronic technology ("POET") platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - today announced key operational, financial position, "Lab-to-Fab" transition, and milestone updates.

Financial Position

"POET enters 2015 in excellent financial shape," noted Mr. Peter Copetti, Co-Chairman and interim CEO. "Although we spent on outsourcing and capital equipment through 2014, we start the new year with a cash balance of approximately $12.5 million, a 350% increase from a year earlier. This is our strongest cash position as a company and will allow us to take advantage of opportunities in the following year to maximize shareholder value." In December 2014, the Company also signed a new lease extension with the University of Connecticut ("UCONN") for a 1-year period which was pre-paid at a significant discount. The new lease includes a possible further two-year extension and provides us the flexibility to transition from Lab to Fab.

Mr. Copetti added: "2014 has been a great year for POET where our transition from "Lab-to-Fab" has begun with many industry Non-Disclosure Agreement ("NDA") discussions that have been initiated through the work of Mr. Ajit Manocha, our Co-Chairman. Some of our milestones have had to evolve during 2014 because of industry relationship considerations and priorities. These evolving changes have made the updated milestones more significant to the market place. We enter 2015 with financial stability, significant industry relationships, and milestones relevant to the industry collaborators. The Company believes that we are in an excellent position to monetize our process technology."

"Lab-to-Fab" Transition: 100-nm and 40-nm Scaling Program Update

POET recently reported a contractual effort with a "3rd party foundry" to accelerate the transition from "Lab-to-Fab" of the POET technology to a manufacturing status at the 6" wafer scale. Significant progress has been made towards transfer of critical manufacturing steps to the "3rd party foundry". This flow will both accelerate and improve quality of results for prototype fabrication and test supporting process flow and design enablement kit development. Efforts in the lab have been geared towards optimization of the self-aligned contacts for the HFET transistors, as well as on optimization of the vertical structure of the devices. Mr. Daniel DeSimone, Chief Technology Officer noted: "We have seen positive improvement in the key figures of merit we test for in our devices. We see further possible improvements and are continuing to work on device and process flow to achieve the highest possible performance."

In a parallel development at the UCONN lab, a new additional sputter tool was received and accepted. The tool is nearing completion of internal qualification. Deployment of the new tool will drastically reduce prototype fabrication cycle times as well as improve the quality and process control of key films used in the process flow. These will be critical not only to current development, but also necessary for transfer to eventual manufacturing stages.

Milestone Updates

PET Foundation Process Design Kit ("PDK") targeting 40-nm - Sentaurus modeling (a Synopsys tool) has been performed with new fabrication innovations to achieve controlled scaled device operation. These modeling predictions are guiding and confirming the device prototype development and testing. The PDK milestone has been moved to Q1 2015 so that the release incorporates the latest innovations currently being developed in the UCONN Lab and in parallel with the "3rd party foundry".

"3rd Party Foundry" 40/100-nm Transfer - This "Lab-to-Fab" effort requires bringing up critical layers manufacturing capability in our "3rd party foundry" which enables more complex test structures. Significant progress has been achieved towards the completion of this milestone. The Company is very close to completing qualification runs for the flow in which the critical layers are performed at our "3rd party foundry". This new flow will significantly accelerate completion and optimization of development on 100 and 40-nm foundation devices and associated proof of concept optical and electronic circuit structures.

CEO Search Update

POET recently announced that Mr. Ajit Manocha, Co-Chairman had been appointed to the Corporate Governance and Nominating Committee, subject to Board approval, with the mandate to identify and consider candidates for the permanent Chief Executive Officer role. Mr. Manocha noted: "Several high quality candidates are being considered. We hope in the near term to identify POET's permanent CEO who will continue the process technology development and help us close key industry partnership deals. We look forward to identifying the right successor."

In addition, over the next few months, the Company intends to add directors, key executives and operational staff focusing on increasing POET's presence in the United States.
Zoals gewoonlijk, 'veel geschreeuw en weinig wol'.

En zo zal dat nog vele jaren doorgaan totdat het geld op is en niemand meer gelooft in de sprookjes van POET.
[verwijderd]
0
Altijd handig als dwz zichzelf beschrijft:
"veel geschreeuw en weinig wol"... LOL
[verwijderd]
0
quote:

DeZwarteRidder schreef op 8 januari 2015 19:59:

[...]

Zoals gewoonlijk, 'veel geschreeuw en weinig wol'.

En zo zal dat nog vele jaren doorgaan totdat het geld op is en niemand meer gelooft in de sprookjes van POET.
Moet je dan echt de post helemaal quoten riddert? Zo onoverzichtelijk joh.
DeZwarteRidder
0
quote:

doewap schreef op 9 januari 2015 07:25:

[...]

Moet je dan echt de post helemaal quoten riddert? Zo onoverzichtelijk joh.
Daar heb je in principe helemaal gelijk in, maar heel veel mooie en dure woorden gebruiken die niks opleveren is het kenmerk van POET.
Dus stuur maar een klacht aan het PR-buro van POET.
[verwijderd]
0
quote:

DeZwarteRidder schreef op 9 januari 2015 09:57:

[...]

Daar heb je in principe helemaal gelijk in, maar heel veel mooie en dure woorden gebruiken die niks opleveren is het kenmerk van POET.
Dus stuur maar een klacht aan het PR-buro van POET.
Inderdaad, mooi en duur:
www.tafel-design.nl/Bureau-Poet-p-163...
DeZwarteRidder
0
quote:

hosternokke schreef op 9 januari 2015 11:52:

[...]
Inderdaad, mooi en duur:
www.tafel-design.nl/Bureau-Poet-p-163...
Zo te zien kan POET beter meubels gaan verkopen: dan kunnen ze misschien ooit nog winst gaan maken......
[verwijderd]
0
Lekker op 2e paasdag met z'n honderdduizenden in de file aanschuiven naar de meubelboulevard.
forza jake
0
Hallo De Zwarte Ridder,mijn complimenten voor je goede inzichten en aanbevelingen mbt GTAT,Solazyme en Poet. Heb je ook nog tips voor aandelen die wel een grote kans hebben op stijging?
DeZwarteRidder
0
quote:

jake schreef op 9 januari 2015 12:28:

Hallo De Zwarte Ridder,mijn complimenten voor je goede inzichten en aanbevelingen mbt GTAT,Solazyme en Poet. Heb je ook nog tips voor aandelen die wel een grote kans hebben op stijging?
Niet in deze categorie, maar in NL zou je kunnen denken aan AMG, Docdata, Kendrion.

En de olie-aandelen zijn of worden binnenkort koopwaardig omdat de olieprijsdaling nooit erg lang kan duren.
forza jake
0
quote:

DeZwarteRidder schreef op 9 januari 2015 13:13:

[...]

Niet in deze categorie, maar in NL zou je kunnen denken aan AMG, Docdata, Kendrion.

En de olie-aandelen zijn of worden binnenkort koopwaardig omdat de olieprijsdaling nooit erg lang kan duren.
AMG is zeker aantrekkelijk. In the US,ga ik op dit moment voor BIND en RSH. Bedankt voor je advies.
[verwijderd]
0
1,688,000 Warrants (W's) exercised.

At the end of Q3 the OS for W's was 32,083,914.
Exercised since then 432,000 + 25,000 + 1,688,000 = 2,145,000

10,186,000 - 2,145,000 = 8,041,000 left to go before Feb 15.
In total there are 32,083,914 - 2,145,000 = 29,563,914 Warrants outstanding until September 27, 2016.

Shares Outstanding ao Jan 10, 2015: 168,701,084
OS Balance of Warrants Jan 10, 2015: 29,563,914
OS Balance of Options: Jan 10, 2015: 25,947,750
Fully Diluted shares: Jan 10, 2015: 224,212,748
Public Trading Float: Jan 10, 2015: 151,147,138

My own calculation of the Float as of Jan 10, 2015:
168,701,084 (OS) - 17,553,946 (Commons of Insiders) = 151,147,138

Balance of the OS a/o Jan 01, 2014: 132,676,115
Balance of the OS a/o Mar 31, 2014: 148,335,985
Balance of the OS a/o Jun 30, 2014: 159,569,759
Balance of the OS a/o Sep 30, 2014: 163,881,884
Balance of the OS a/o Dec 31, 2014: 166,578,084

Shares issued in Q1 2015:
Commons: 300,000 10,000 25,000
Options: 100,000
Warrants: 1,688,000

Shares issued in Q4 2014:
Commons: 1,864,250
Options: 260,000
Warrants: 457,000

infoventure.tsx.com/TSXVenture/TSXVen...

PS I cannot guarantee a 100% accuracy on these #'s but I'm close to it. DYODD
[verwijderd]
0
www.semiconductors.org/news/2015/01/0...

Neem een half procent van de markt aan royalty revenue.

Dat is dan 145 miljoen per MAAND. Dus 1740 miljoen per jaar. Bij een conservatieve multiple van 12 is dat 20,88 miljard beurswaarde.

Elk miljard beurswaarde is 4,5 dollar per aandeel.

Ik kom op een doel van 93,96 en ik weet heel goed hoe dat klinkt. Het is maar een sommetje voor de lol.

Overigens verschilt het niet zo veel met de beurswaarde van ARM Holdings, het ideale rolmodel voor POET. En ARM deed in 2009 nog minder dan 5 dollar.
[verwijderd]
0
Bij het onvolprezen Wolfram Alpha kan je marktkapitalisatie geschiedenis opvragen

Kies bij de History drop down de optie All Data

m.wolframalpha.com/input/?i=market+ca...
[verwijderd]
0
Niks persoonlijks Seven, maar fairchijisback stelt je cijfers ter discussie:

vreemd dat hij de balans per 31-12-13 neemt.

Zijn er in 2014 geen warrants uitgegeven? ik denk het wel, aan Manocha bijvoorbeeld.

Maar natuurlijk blijft een verschil van bijna 100 miljoen aandelen wel behoorlijk.

of heeft FJ het hier alleen maar over de float...?

-----------------------------------------------------------------------------

Re: warrants
in response to warrants by ahasja
posted on Jan 11, 15 10:59AM (Log in to use the IP Check tool) [?]

(onnodige en vervelende inleiding door mij weggehaald)

He apparently is using the description contained in the Market Capitalization report and filling in a blank under the treasury orders and calling it the issue of common shares? POET issues shares under private placement, or from the exercise of warrants or the exercise of options. They did issue share to UCONN for the royalty adjustment but I have never seen shares issued for any other reasons.

There are no dividends...no DRIP where by the issuer is constantly issuing shares as a dividend payout.

And they are not paying out shares from treasury for services at least none have been reported thus far that I am aware of. So what is the source of these issued common shares that Seven is pointing to?

Below is the last complete years end reporting. The share count increased by shares issued in the private placement, shares exercised as warrant and shares exercised as ptions.

Balance, January 1, 2013

117,528,615

Shares issued on the exercise of stock options

607,500

Shares issued on private placement

14,400,000

Shares issued on exercise of warrants and compensation warrants

140,000

132,676,115

total

Balance, December 31, 2013

132,676,115

Below is the most up to date calculation that I have done using strictly the share count and ignoring the notes which do not specifically state the treasury order source.

If someone has a better explanation I am all ears.

The warrants left to be exercised by mid Feb

Below is the POET’s Option plan as it applies to Directors and Officers who have not been terminated with cause.
(ii) If an Optionee ceases to be either a Director or Officer of the Corporation or any of its subsidiaries for any reason other than as a result of having been dismissed for cause as provided in section 6 (n)or as a result of the Optionee=s death, such Optionee shall have the right for a period of 180 days(or until the normal expiry date of the option rights of such Optionee if earlier) from the date of ceasing to be either a Director or Officer to exercise the option under the Plan with respect to all Optioned Shares of such Optionee to the extent they were exercisable on the date of ceasing to be either a Director or Officer. Upon the expiration of such 180 day period all unexercised option rights of that Optionee shall immediately become terminated and shall lapse notwithstanding the original term of the option granted to such Optionee under the Plan.

Sam Peralta has until mid-May to exercise his options,

Lee Shepherd has until the beginning of May to exercise his.

On Sept 30 the outstanding share count was 163.9 million on Jan 9 the share count was 168.7 million. The difference is 4.8 million.
On Sept 30 there were 10,186,000 warrants at .75. The increase in the share count since that date would indicate that 5,366,800 warrants remain to be exercised. The description applied in the report indicates that up to 385,000 of the share count increase were the result of options being exercised. If that figure is accurate then 5.75 million warrants remain to be exercised by mid Feb. If one assumes that the owners of these warrants do not have the cash to pay for these warrants or have failed to sell enough shares ahead of the expiry date then the overhang represented would be roughly 2.8 million shares at $1.50 (over the next 22 trading sessions or 127k a day in selling pressure). Again this would only be the case if the warrant holders failed to plan the purchase in advance. This assumes that no block trades will take place to move a large number of these shares but as we have seen there are in fact a significant number of block trades. Also if we look at the most recent exercise of 1.7 million warrants exercised it is difficult to assign too much down ward pressure from that transaction.
I expect this talk about any significant impact to the share price as way over stated. There was a lot of talk here from the usual suspects when the shares from the most recent raise came off hold and the share price did not go down it went up.
And between then and now there could be some significant news.
[verwijderd]
0
Heb 't net gezien doewap, maar FJ zit er compleet naast!
Hij beweert stellig dat er nog zo'n 5 mil Warrants uit te oefenen zijn.
Maar als je de info op de TSX bekijkt dan zijn er tot nu toe maar zo'n 2 mil uitgegeven.

Do the math infoventure.tsx.com/TSXVenture/TSXVen...

Hij durft ook te beweren dat PTK geen Commons heeft uitgegeven, terwijl er in 't vorig kwartaal 1.8 mil zijn bijgekomen. Men hoeft enkel de data te checken op de TSX site om te zien dat ik gelijk heb. Alhoewel er niemand op Angrycom de gevreesde leider durft tegen te spreken LOL

Het enige waar ik verkeerd in ben is de datum waarin de Opties van degene die PTK hebben verlaten kunnen uitgeoefend worden. Normaal gezien is dit 90 dagen na hun vertrek. Ik heb dit aangenomen zonder te checken bij Peralta & Shepherd, die klaarblijkelijk 180 dagen hebben.
www.stockhouse.com/companies/bullboar...

Deze #'s zijn correct! Bekijk ze maar op de TSX site & de Q rapporten.
Exercised Warrants since the end of Q3 432,000 + 25,000 + 1,688,000 = 2,145,000
Warrants 10,186,000 - 2,145,000 = 8,041,000 left to go before Feb 15.
www.stockhouse.com/companies/bullboar...
3.207 Posts, Pagina: « 1 2 3 4 5 6 ... 116 117 118 119 120 121 122 123 124 125 126 ... 157 158 159 160 161 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

 AEX
903,61  -1,97  -0,22%  31 mei
 Germany40^ 18.585,90 +0,48%
 BEL 20 3.918,09 +0,24%
 EURO50 5.011,20 0,00%
 US30^ 38.701,80 0,00%
 Nasd100^ 18.538,90 0,00%
 US500^ 5.280,42 0,00%
 Japan225^ 38.630,50 0,00%
 Gold spot 2.327,41 0,00%
 EUR/USD 1,0834 +0,00%
 WTI 77,14 0,00%
#/^ Index indications calculated real time, zie disclaimer

Stijgers

VIVORYON THER... +19,75%
RENEWI +2,79%
Air France-KLM +2,20%
Vastned +2,07%
UMG +1,89%

Dalers

JDE PEET'S -4,89%
ASR Nederland -4,88%
Corbion -3,41%
Avantium -2,66%
PROSUS -2,33%

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront